Zobrazeno 1 - 10
of 265
pro vyhledávání: '"Min Kyong Moon"'
Autor:
Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, Suk Chon, Dae Jung Kim, Hyun Jin Kim, Nan Hee Kim, Ji A Seo, Mee Kyoung Kim, Jeong Hyun Lim, YoonJu Song, Ye Seul Yang, Jae Hyeon Kim, You-Bin Lee, Junghyun Noh, Kyu Yeon Hur, Jong Suk Park, Sang Youl Rhee, Hae Jin Kim, Hyun Min Kim, Jung Hae Ko, Nam Hoon Kim, Chong Hwa Kim, Jeeyun Ahn, Tae Jung Oh, Soo-Kyung Kim, Jaehyun Kim, Eugene Han, Sang-Man Jin, Won Suk Choi, Min Kyong Moon
Publikováno v:
Diabetes & Metabolism Journal, Vol 47, Iss 5, Pp 575-594 (2023)
In May 2023, the Committee of Clinical Practice Guidelines of the Korean Diabetes Association published the revised clinical practice guidelines for Korean adults with diabetes and prediabetes. We incorporated the latest clinical research findings th
Externí odkaz:
https://doaj.org/article/4c23615200e742e2b7dfd04326d95f4e
Autor:
Hae Jin Kim, Jung Hyun Noh, Min Kyong Moon, Sung Hee Choi, Seung-Hyun Ko, Eun-Jung Rhee, Kyu Yeon Hur, In-Kyung Jeong
Publikováno v:
Journal of Diabetes Research, Vol 2024 (2024)
Background. We aimed to compare efficacy and safety between gemigliptin add-on and escalation of the metformin dose in patients with inadequately controlled type 2 diabetes mellitus (T2DM) despite treatment with metformin and SGLT2 inhibitors. Method
Externí odkaz:
https://doaj.org/article/945d9462859b469bb898685d604a1a24
Autor:
Min Kyong Moon, Hyeonjung Ham, Soo Min Song, Chanhee Lee, Taewan Goo, Bumjo Oh, Seungyeoun Lee, Shin-Woo Kim, Taesung Park
Publikováno v:
Frontiers in Medicine, Vol 10 (2024)
BackgroundUnderstanding the clinical course and pivotal time points of COVID-19 aggravation is critical for enhancing patient monitoring. This retrospective, multi-center cohort study aims to identify these significant time points and associate them
Externí odkaz:
https://doaj.org/article/7b7f20c468a44eda8237844f6dda49f3
Publikováno v:
Diabetes & Metabolism Journal, Vol 47, Iss 2, Pp 201-210 (2023)
Background We evaluated the validity and reliability of the operational definition of type 2 diabetes mellitus (T2DM) based on the Korean National Health Insurance Service (NHIS) database. Methods Adult subjects (≥40 years old) included in the Kore
Externí odkaz:
https://doaj.org/article/f3a3725417f04734a41d5834e4e364fb
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
IntroductionThe influence of dietary patterns measured using Recommended Food Score (RFS) with foods with high amounts of antioxidant nutrients for Type 2 diabetes (T2D) was analyzed. Our analysis aims to find associations between dietary patterns an
Externí odkaz:
https://doaj.org/article/f0f772384f5044b6b9bd4997de403bbf
Autor:
Min Kyong Moon, Junghyun Noh, Eun-Jung Rhee, Sang Hyun Park, Hyeon Chang Kim, Byung Jin Kim, Hae Jin Kim, Seonghoon Choi, Jin Oh Na, Young Youl Hyun, Bum Joon Kim, Kyung-Do Han, In-Kyung Jeong
Publikováno v:
Diabetes & Metabolism Journal, Vol 47, Iss 1, Pp 45-58 (2023)
Background There are no clear data to support the cardiovascular (CV) risk categories and low-density lipoprotein cholesterol (LDL-C) treatment goals in Korean people with type 2 diabetes mellitus (T2DM). We evaluated the incidence of cardiovascular
Externí odkaz:
https://doaj.org/article/48295347ec1844e1a4a278953ff56fa1
Autor:
Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon
Publikováno v:
Diabetes & Metabolism Journal, Vol 47, Iss 1, Pp 10-26 (2023)
Diabetes mellitus is a major risk factor for the development of heart failure. Furthermore, the prognosis of heart failure is worse in patients with diabetes mellitus than in those without it. Therefore, early diagnosis and proper management of heart
Externí odkaz:
https://doaj.org/article/989d7e2e35d841f6ad8d73370325d662
Publikováno v:
Diabetes & Metabolism Journal, Vol 47, Iss 1, Pp 1-9 (2023)
Dyslipidemia in patients with diabetes is an important treatment target as a modifiable risk factor for cardiovascular disease (CVD). Although the primary treatment goal for dyslipidemia is to control low-density lipoprotein cholesterol (LDL-C), achi
Externí odkaz:
https://doaj.org/article/a2342494f8c4454283a4bbdc0fc0cfbc
Autor:
Junghyun Noh, Min Kyong Moon, Eun-Jung Rhee, Sang Hyun Park, Hyeon Chang Kim, Byung Jin Kim, Hae Jin Kim, Seonghoon Choi, Jin Oh Na, Young Youl Hyun, Bum Joon Kim, Kyung-Do Han, In-Kyung Jeong
Publikováno v:
Diabetes & Metabolism Journal, Vol 47, Iss 1, Pp 59-71 (2023)
Background To validate the treatment target of low-density lipoprotein cholesterol (LDL-C) level according to the cardiovascular disease (CVD) risk which was recommended by Korean dyslipidemia guideline. Methods We used the Korean National Health Ins
Externí odkaz:
https://doaj.org/article/b2246e23536f4b9bb95296c2d7d4839d
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 1, Pp 93-100 (2023)
Background/Aims The Korean Diabetes Association (KDA) guidelines recommend adults aged ≥ 40 years and adults aged ≥ 30 years with diabetes risk factors for diabetes screening. This study aimed to determine the age threshold for diabetes screening
Externí odkaz:
https://doaj.org/article/6f4b7b56862b4d629663031d29288fc1